GENEO Capital Entrepreneur, Bpifrance, and NCI have successfully exited their investment in Human & Work, Europe’s leading consulting group focused on workplace human issues, through its acquisition by a prominent Canadian health group.

Information on the Target

Human & Work, the leading European consulting group focused on human resources, specializes in addressing workplace human issues. The company assists Human Resources Directors in nurturing their teams and enhancing organizational well-being. Since the investment by GENEO Capital Entrepreneur, Bpifrance, and NCI on March 14, 2019, under the leadership of David Mahé, Human & Work has executed a strategic plan aimed at establishing itself as the premier authority on workplace human factors in Europe.

Through a robust development strategy and the unique "Carnet de croissance" approach, Human & Work has accelerated its growth by providing tailored support that combines strategic expertise and financial backing, while also emphasizing internal team value through equity-sharing mechanisms. This collaboration highlights GENEO Capital Entrepreneur's ability to unlock potential in its partner companies, laying the groundwork for sustainable leadership in Europe.

Industry Overview in Germany

The consulting industry in Germany is undergoing significant transformations, driven by an increasing need for expertise in managing human capital as organizations strive to maintain a competitive advantage